Structure–Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants

[Image: see text] There are currently no effective therapies for fibrodysplasia ossificans progressiva (FOP), a debilitating and progressive heterotopic ossification disease caused by activating mutations of ACVR1 encoding the BMP type I receptor kinase ALK2. Recently, a subset of these same mutatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mohedas, Agustin H., Wang, You, Sanvitale, Caroline E., Canning, Peter, Choi, Sungwoon, Xing, Xuechao, Bullock, Alex N., Cuny, Gregory D., Yu, Paul B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2014
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4191596/
https://ncbi.nlm.nih.gov/pubmed/25101911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm501177w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados